ARCHIVES

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

This article is from The Cancer Letter archive.

Vol. 35 No. 23 | June 12, 2009

Download PDF Visit The Full Archive

Related Articles

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

Avastin Combination Approved For Metastatic Colorectal Cancer

February 22, 2013

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

NCI Cancer Education Program To Open To Innovative Ideas

April 2, 1993